In the News

09/10/2018

Petuum and Cleveland Clinic join forces for AI XPRIZE competition

At Petuum, we firmly believe that humans can and should collaborate with AI technology to build things that make the world better. Our mission is to industrialize AI and make the technology widely accessible and usable so that, with our intuitive machine learning building blocks, anyone can create an AI solution that addresses challenges big and small.

We are excited to announce that we are collaborating with Cleveland Clinic, a leading academic medical center, on the submission of an AI-powered diagnostic tool to the IBM Watson AI XPRIZE challenge. XPRIZE is an open challenge sponsored by IBM Watson to develop AI technology that collaborates with humans to address societal challenges. The multi-year competition closed its latest submission round on September 8 with 62 teams competing worldwide.


08/20/2018

Cleveland Clinic, Parker Hannifin create catheter to treat brain tumors

During his two-decade career as a neurosurgeon, Dr. Michael Vogelbaum has seen little progress in the treatment ofglioblastoma, an aggressive brain cancer that is difficult to treat or cure.


08/06/2018

Potential new class of drugs may reduce cardiovascular risk by targeting gut microbes

Developed at Cleveland Clinic, the non-antibiotic compounds, tested in animal models, prevented production of gut byproduct linked to heart attack and stroke in humans


07/31/2018

Ohio and heartland must embrace the "innovation economy," report says

When it comes to taking advantage of the so-called "innovation-based economy," where does Ohio rank? 


06/28/2018

Plug and Play Hosts Expo Day in Cleveland

In Spring 2018, Plug and Play Cleveland Innovation Platform began its first inaugural Health & Wellness accelerator program.

Plug and Play started with about one-thousand candidates and then narrowed down that list to 50. They shared that list with the Cleveland Clinic and JumpStart and then arrived at 13 companies.


06/01/2018

Cleveland Clinic spinoff develops mouthguard that accesses concussion effects

The atmosphere inside the boxing gym was humid and reeked of sweat. Antonio Nieves, a former Cleveland Golden Gloves champion bantamweight, adjusted his digital mouthguard as he waited for his sparring match to start.


05/30/2018

ClearFlow Announces Additional Positive US Clinical Trial Results at the 2018 NTI Critical Care Exposition

ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results were presented at the National Teaching Institute (NTI) & Critical Care Exposition 2018 annual meeting on May 23rd, 2018 in Boston, MA. The findings were presented by the study principal investigator, Dr. Yvon Baribeau, of Catholic Medical Center in Manchester, New Hampshire, in a presentation titled “Active Clearance of Chest Drains Reduces Pleural Effusions and ICU Resources in patients undergoing Cardiac Surgery.”


05/29/2018

ClearFlow Announces Additional Positive US Clinical Trial Results at the 2018 NTI Critical Care Exposition

ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results were presented at the National Teaching Institute (NTI) & Critical Care Exposition 2018 annual meeting on May 23rd, 2018 in Boston, MA. The findings were presented by the study principal investigator, Dr. Yvon Baribeau, of Catholic Medical Center in Manchester, New Hampshire, in a presentation titled “Active Clearance of Chest Drains Reduces Pleural Effusions and ICU Resources in patients undergoing Cardiac Surgery.”


05/29/2018

Cleveland Clinic spinoff is at the center of efforts to remake the operating room

Centerline Biomedical, a Cleveland Clinic spinoff, is part of this Wall Street Journal story about tech advances that are making the operating room "smarter, more effective — and a lot less risky for patients."


05/29/2018

Merchavia Reports Positive Results in a Breakthrough Trial for Early Prostate Cancer Diagnosis

Merchavia Holdings and Investments (TASE: MRHL), an Israeli investment company specializing in early-stage life science sector companies, reports positive results from a successful trial which was conducted Cleveland Clinic, a leading medical center, using IsoPSA, a test developed by CDx (in which Merchavia holds about 8%).


   <  7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - 16  >   

Get In Touch With Us